The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Non-Animal Softgel Capsules Market Research Report 2025
Synopsis
Non-animal Softgel Capsules is a kind of Softgels, a solid outer shell and inner surrounding a liquid or semi-solid (inner fill) active ingredient that can be incorporated into the outer shell, the inner fill, or both.
Non-animal Softgel Capsules are all-natural, GMO free, plant-based shell, free from animal derivatives, gluten, and modified sugars. Nowadays, Non-animal Softgel Capsules can be divided into several kinds such as Plant Polysaccharides (Pullulan), Starches, and Hydroxyl Propyl Methyl Celluloses. Non-animal Softgel Capsules possess the benefits of suited for Halal or Kosher certification; Pure, clear and elegant appearance with no taste or odor; Ideal for improving the bioavailability of oil soluble ingredients; Easy to swallow, safe, non-carcinogenic and tamper evident, etc.
The global Non-Animal Softgel Capsules market was valued at US$ 553 million in 2023 and is anticipated to reach US$ 904.8 million by 2030, witnessing a CAGR of 7.2% during the forecast period 2024-2030.
Catalent, Procaps Laboratorios, Aenova, Bahrain Pharma, Robinson Pharma, etc. are the key vendors in the global vegetarian softgel capsules market. The top 5 took up more than 70% of the global market. Catalent, Procaps Laboratorios, Aenova, etc. which have leading technology and market position, are well-known vendors around the world.
Americas is the largest region of vegetarian softgel capsules in the world, which takes up about 47% of the global revenue market, while Europe and the Asia Pacific were about 23%, 20% respectively.
Vegetarian softgel capsules are mainly classified into the following types: plant polysaccharides and starch. Plant polysaccharides is the most widely used type which takes up about 75% of the total sales.
This product also has a wide range of applications, such as health supplements, pharmaceuticals, etc. And health supplements sector was the most widely used area which accounts for over 75% of the global total, the application in pharmaceutical focuses on OTC products.
This report aims to provide a comprehensive presentation of the global market for Non-Animal Softgel Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Animal Softgel Capsules.
Report Scope
The Non-Animal Softgel Capsules market size, estimations, and forecasts are provided in terms of sales volume (M Capsules) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-Animal Softgel Capsules market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-Animal Softgel Capsules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Catalent
Procaps Laboratorios
EuroCaps
Best Formulations
Aenova
Captek
Sirio
Bahrain Pharma
Robinson Pharma
Aland
Fuji Capsule
Sunsho Pharmaceutical
Erkang
Segment by Type
Plant Polysaccharides Softgel Capsules
Starch Softgel Capsules
Segment by Application
Health Supplements
Pharmaceutical
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Non-Animal Softgel Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Non-Animal Softgel Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Non-animal Softgel Capsules is a kind of Softgels, a solid outer shell and inner surrounding a liquid or semi-solid (inner fill) active ingredient that can be incorporated into the outer shell, the inner fill, or both.
Non-animal Softgel Capsules are all-natural, GMO free, plant-based shell, free from animal derivatives, gluten, and modified sugars. Nowadays, Non-animal Softgel Capsules can be divided into several kinds such as Plant Polysaccharides (Pullulan), Starches, and Hydroxyl Propyl Methyl Celluloses. Non-animal Softgel Capsules possess the benefits of suited for Halal or Kosher certification; Pure, clear and elegant appearance with no taste or odor; Ideal for improving the bioavailability of oil soluble ingredients; Easy to swallow, safe, non-carcinogenic and tamper evident, etc.
The global Non-Animal Softgel Capsules market was valued at US$ 553 million in 2023 and is anticipated to reach US$ 904.8 million by 2030, witnessing a CAGR of 7.2% during the forecast period 2024-2030.
Catalent, Procaps Laboratorios, Aenova, Bahrain Pharma, Robinson Pharma, etc. are the key vendors in the global vegetarian softgel capsules market. The top 5 took up more than 70% of the global market. Catalent, Procaps Laboratorios, Aenova, etc. which have leading technology and market position, are well-known vendors around the world.
Americas is the largest region of vegetarian softgel capsules in the world, which takes up about 47% of the global revenue market, while Europe and the Asia Pacific were about 23%, 20% respectively.
Vegetarian softgel capsules are mainly classified into the following types: plant polysaccharides and starch. Plant polysaccharides is the most widely used type which takes up about 75% of the total sales.
This product also has a wide range of applications, such as health supplements, pharmaceuticals, etc. And health supplements sector was the most widely used area which accounts for over 75% of the global total, the application in pharmaceutical focuses on OTC products.
This report aims to provide a comprehensive presentation of the global market for Non-Animal Softgel Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Animal Softgel Capsules.
Report Scope
The Non-Animal Softgel Capsules market size, estimations, and forecasts are provided in terms of sales volume (M Capsules) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-Animal Softgel Capsules market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-Animal Softgel Capsules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Catalent
Procaps Laboratorios
EuroCaps
Best Formulations
Aenova
Captek
Sirio
Bahrain Pharma
Robinson Pharma
Aland
Fuji Capsule
Sunsho Pharmaceutical
Erkang
Segment by Type
Plant Polysaccharides Softgel Capsules
Starch Softgel Capsules
Segment by Application
Health Supplements
Pharmaceutical
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Non-Animal Softgel Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Non-Animal Softgel Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Non-Animal Softgel Capsules Market Overview
1.1 Product Overview and Scope of Non-Animal Softgel Capsules
1.2 Non-Animal Softgel Capsules Segment by Type
1.2.1 Global Non-Animal Softgel Capsules Market Value Comparison by Type (2024-2030)
1.2.2 Plant Polysaccharides Softgel Capsules
1.2.3 Starch Softgel Capsules
1.3 Non-Animal Softgel Capsules Segment by Application
1.3.1 Global Non-Animal Softgel Capsules Market Value by Application: (2024-2030)
1.3.2 Health Supplements
1.3.3 Pharmaceutical
1.3.4 Others
1.4 Global Non-Animal Softgel Capsules Market Size Estimates and Forecasts
1.4.1 Global Non-Animal Softgel Capsules Revenue 2019-2030
1.4.2 Global Non-Animal Softgel Capsules Sales 2019-2030
1.4.3 Global Non-Animal Softgel Capsules Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Non-Animal Softgel Capsules Market Competition by Manufacturers
2.1 Global Non-Animal Softgel Capsules Sales Market Share by Manufacturers (2019-2024)
2.2 Global Non-Animal Softgel Capsules Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Non-Animal Softgel Capsules Average Price by Manufacturers (2019-2024)
2.4 Global Non-Animal Softgel Capsules Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Non-Animal Softgel Capsules, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-Animal Softgel Capsules, Product Type & Application
2.7 Non-Animal Softgel Capsules Market Competitive Situation and Trends
2.7.1 Non-Animal Softgel Capsules Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Non-Animal Softgel Capsules Players Market Share by Revenue
2.7.3 Global Non-Animal Softgel Capsules Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non-Animal Softgel Capsules Retrospective Market Scenario by Region
3.1 Global Non-Animal Softgel Capsules Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Non-Animal Softgel Capsules Global Non-Animal Softgel Capsules Sales by Region: 2019-2030
3.2.1 Global Non-Animal Softgel Capsules Sales by Region: 2019-2024
3.2.2 Global Non-Animal Softgel Capsules Sales by Region: 2025-2030
3.3 Global Non-Animal Softgel Capsules Global Non-Animal Softgel Capsules Revenue by Region: 2019-2030
3.3.1 Global Non-Animal Softgel Capsules Revenue by Region: 2019-2024
3.3.2 Global Non-Animal Softgel Capsules Revenue by Region: 2025-2030
3.4 North America Non-Animal Softgel Capsules Market Facts & Figures by Country
3.4.1 North America Non-Animal Softgel Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Non-Animal Softgel Capsules Sales by Country (2019-2030)
3.4.3 North America Non-Animal Softgel Capsules Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Non-Animal Softgel Capsules Market Facts & Figures by Country
3.5.1 Europe Non-Animal Softgel Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Non-Animal Softgel Capsules Sales by Country (2019-2030)
3.5.3 Europe Non-Animal Softgel Capsules Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-Animal Softgel Capsules Market Facts & Figures by Country
3.6.1 Asia Pacific Non-Animal Softgel Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Non-Animal Softgel Capsules Sales by Country (2019-2030)
3.6.3 Asia Pacific Non-Animal Softgel Capsules Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Non-Animal Softgel Capsules Market Facts & Figures by Country
3.7.1 Latin America Non-Animal Softgel Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Non-Animal Softgel Capsules Sales by Country (2019-2030)
3.7.3 Latin America Non-Animal Softgel Capsules Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-Animal Softgel Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-Animal Softgel Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Non-Animal Softgel Capsules Sales by Country (2019-2030)
3.8.3 Middle East and Africa Non-Animal Softgel Capsules Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Non-Animal Softgel Capsules Sales by Type (2019-2030)
4.1.1 Global Non-Animal Softgel Capsules Sales by Type (2019-2024)
4.1.2 Global Non-Animal Softgel Capsules Sales by Type (2025-2030)
4.1.3 Global Non-Animal Softgel Capsules Sales Market Share by Type (2019-2030)
4.2 Global Non-Animal Softgel Capsules Revenue by Type (2019-2030)
4.2.1 Global Non-Animal Softgel Capsules Revenue by Type (2019-2024)
4.2.2 Global Non-Animal Softgel Capsules Revenue by Type (2025-2030)
4.2.3 Global Non-Animal Softgel Capsules Revenue Market Share by Type (2019-2030)
4.3 Global Non-Animal Softgel Capsules Price by Type (2019-2030)
5 Segment by Application
5.1 Global Non-Animal Softgel Capsules Sales by Application (2019-2030)
5.1.1 Global Non-Animal Softgel Capsules Sales by Application (2019-2024)
5.1.2 Global Non-Animal Softgel Capsules Sales by Application (2025-2030)
5.1.3 Global Non-Animal Softgel Capsules Sales Market Share by Application (2019-2030)
5.2 Global Non-Animal Softgel Capsules Revenue by Application (2019-2030)
5.2.1 Global Non-Animal Softgel Capsules Revenue by Application (2019-2024)
5.2.2 Global Non-Animal Softgel Capsules Revenue by Application (2025-2030)
5.2.3 Global Non-Animal Softgel Capsules Revenue Market Share by Application (2019-2030)
5.3 Global Non-Animal Softgel Capsules Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Catalent
6.1.1 Catalent Corporation Information
6.1.2 Catalent Description and Business Overview
6.1.3 Catalent Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Catalent Non-Animal Softgel Capsules Product Portfolio
6.1.5 Catalent Recent Developments/Updates
6.2 Procaps Laboratorios
6.2.1 Procaps Laboratorios Corporation Information
6.2.2 Procaps Laboratorios Description and Business Overview
6.2.3 Procaps Laboratorios Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Procaps Laboratorios Non-Animal Softgel Capsules Product Portfolio
6.2.5 Procaps Laboratorios Recent Developments/Updates
6.3 EuroCaps
6.3.1 EuroCaps Corporation Information
6.3.2 EuroCaps Description and Business Overview
6.3.3 EuroCaps Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2019-2024)
6.3.4 EuroCaps Non-Animal Softgel Capsules Product Portfolio
6.3.5 EuroCaps Recent Developments/Updates
6.4 Best Formulations
6.4.1 Best Formulations Corporation Information
6.4.2 Best Formulations Description and Business Overview
6.4.3 Best Formulations Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Best Formulations Non-Animal Softgel Capsules Product Portfolio
6.4.5 Best Formulations Recent Developments/Updates
6.5 Aenova
6.5.1 Aenova Corporation Information
6.5.2 Aenova Description and Business Overview
6.5.3 Aenova Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Aenova Non-Animal Softgel Capsules Product Portfolio
6.5.5 Aenova Recent Developments/Updates
6.6 Captek
6.6.1 Captek Corporation Information
6.6.2 Captek Description and Business Overview
6.6.3 Captek Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Captek Non-Animal Softgel Capsules Product Portfolio
6.6.5 Captek Recent Developments/Updates
6.7 Sirio
6.6.1 Sirio Corporation Information
6.6.2 Sirio Description and Business Overview
6.6.3 Sirio Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sirio Non-Animal Softgel Capsules Product Portfolio
6.7.5 Sirio Recent Developments/Updates
6.8 Bahrain Pharma
6.8.1 Bahrain Pharma Corporation Information
6.8.2 Bahrain Pharma Description and Business Overview
6.8.3 Bahrain Pharma Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bahrain Pharma Non-Animal Softgel Capsules Product Portfolio
6.8.5 Bahrain Pharma Recent Developments/Updates
6.9 Robinson Pharma
6.9.1 Robinson Pharma Corporation Information
6.9.2 Robinson Pharma Description and Business Overview
6.9.3 Robinson Pharma Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Robinson Pharma Non-Animal Softgel Capsules Product Portfolio
6.9.5 Robinson Pharma Recent Developments/Updates
6.10 Aland
6.10.1 Aland Corporation Information
6.10.2 Aland Description and Business Overview
6.10.3 Aland Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Aland Non-Animal Softgel Capsules Product Portfolio
6.10.5 Aland Recent Developments/Updates
6.11 Fuji Capsule
6.11.1 Fuji Capsule Corporation Information
6.11.2 Fuji Capsule Non-Animal Softgel Capsules Description and Business Overview
6.11.3 Fuji Capsule Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Fuji Capsule Non-Animal Softgel Capsules Product Portfolio
6.11.5 Fuji Capsule Recent Developments/Updates
6.12 Sunsho Pharmaceutical
6.12.1 Sunsho Pharmaceutical Corporation Information
6.12.2 Sunsho Pharmaceutical Non-Animal Softgel Capsules Description and Business Overview
6.12.3 Sunsho Pharmaceutical Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Sunsho Pharmaceutical Non-Animal Softgel Capsules Product Portfolio
6.12.5 Sunsho Pharmaceutical Recent Developments/Updates
6.13 Erkang
6.13.1 Erkang Corporation Information
6.13.2 Erkang Non-Animal Softgel Capsules Description and Business Overview
6.13.3 Erkang Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Erkang Non-Animal Softgel Capsules Product Portfolio
6.13.5 Erkang Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-Animal Softgel Capsules Industry Chain Analysis
7.2 Non-Animal Softgel Capsules Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-Animal Softgel Capsules Production Mode & Process
7.4 Non-Animal Softgel Capsules Sales and Marketing
7.4.1 Non-Animal Softgel Capsules Sales Channels
7.4.2 Non-Animal Softgel Capsules Distributors
7.5 Non-Animal Softgel Capsules Customers
8 Non-Animal Softgel Capsules Market Dynamics
8.1 Non-Animal Softgel Capsules Industry Trends
8.2 Non-Animal Softgel Capsules Market Drivers
8.3 Non-Animal Softgel Capsules Market Challenges
8.4 Non-Animal Softgel Capsules Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
